dosReis, Susan http://orcid.org/0000-0003-2210-6650
Butler, Beverly
Caicedo, Juan
Kennedy, Annie
Hong, Yoon Duk
Zhang, Chengchen
Slejko, Julia F.
Funding for this research was provided by:
Pharmaceutical Research and Manufacturers of America Foundation
Article History
First Online: 17 July 2020
Compliance with Ethical Standards
:
: This work was funded by a grant from the Pharmaceutical Researchers and Manufacturers of America (PhRMA) Foundation Center of Excellence in Value Assessment Award. The views expressed in this manuscript were not contingent upon approval from or influenced by the PhRMA Foundation.
: Susan dosReis received grant funding from the National Institute of Mental Health (NIMH) and the Patient Centered Outcomes Research Institute (PCORI), the US FDA, the Pharmaceutical Researchers and Manufacturers of America (PhRMA) Foundation, and GlaxoSmithKline. Ms. Kennedy is employed by the EveryLife Foundation for Rare Diseases, a bipartisan nonprofit patient organization dedicated to rare disease policy and advocacy. Foundation funding includes biopharmaceutical industry support; full details can be found at ExternalRef removed. Julia F. Slejko received grant funding from the PhRMA Foundation, Novartis Pharmaceuticals, and Takeda Pharmaceuticals and teaching honorarium from PfizerĀ unrelated to the submitted work. Beverly Butler, Juan Caicedo, Yoon Duk Hong, and Chengchen Zhang have no conflicts of interest that are directly relevant to the content of this article.
: The ESM provides the search terms used to identify relevant literature and all data summarized at each phase of this formative work. This enables transparency and access to the data generated from this research. There are no software codes or analytical models related to this work.